Associated Papers
Crystal structures of human and mouse ketohexokinase provide a structural basis for species- and isoform-selective inhibitor design.
Ebenhoch R et al.
Acta Crystallographica. Section D, Structural Biology, 2023
Prevalence and cardiometabolic correlates of ketohexokinase gene variants among UK Biobank participants.
Johnston JA et al.
Plos One, 2021
Genomic profiling of multiple sequentially acquired tumor metastatic sites from an "exceptional responder" lung adenocarcinoma patient reveals extensive genomic heterogeneity and novel somatic variants driving treatment response.
Biswas R et al.
Cold Spring Harbor Molecular Case Studies, 2016
27900369 (PubMed )
Supplement: supp_mcs.a001263_SuppTable_S3.xlsx › Supplementary_Table_S3_A
Integrated analysis of germline and somatic variants in ovarian cancer.
Kanchi KL et al.
Nature Communications, 2014
24448499 (PubMed )
Supplement: NIHMS551112-supplement-9.xlsx › S_Data_8
Structures of alternatively spliced isoforms of human ketohexokinase.
Trinh CH et al.
Acta Crystallographica. Section D, Biological Crystallography, 2009
Properties of normal and mutant recombinant human ketohexokinases and implications for the pathogenesis of essential fructosuria.
Asipu A et al.
Diabetes, 2003
Molecular genetics of the human glucokinase regulator-fructokinase (GCKR-KHK) region of chromosome 2p23.
Hayward BE et al.
Biochemical Society Transactions, 1997
Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase).
Bonthron DT et al.
Human Molecular Genetics, 1994
Select a paper to view details